Carsten Boess

Insider Reports History

Location
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Signature
/s/ Martin Wilson, as attorney-in-fact for Carsten Boess
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carsten Boess:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. Director Common Stock 30K $236K $7.86 Jun 18, 2025 Direct
Avidity Biosciences, Inc. Director Common Stock 6.69K $196K $29.33 Jun 10, 2025 Direct
Avidity Biosciences, Inc. Director Stock Option (Right to Buy) 10K Jun 10, 2025 Direct

Insider Reports Filed by Carsten Boess

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCKT ROCKET PHARMACEUTICALS, INC. Jun 18, 2025 1 $0 4 Jul 18, 2025 Director
RNA Avidity Biosciences, Inc. Jun 10, 2025 2 $0 4 Jun 12, 2025 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 13, 2024 1 $0 4 Jun 20, 2024 Director
RNA Avidity Biosciences, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
RNA Avidity Biosciences, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
RNA Avidity Biosciences, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director
RNA Avidity Biosciences, Inc. Jun 16, 2021 1 $0 4 Jun 16, 2021 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 14, 2021 1 $0 4 Jun 16, 2021 Director